ABIONYX Pharma SA (EPA:ABNX)
France
· Delayed Price · Currency is EUR 1.808
-0.038 (-2.06%)
Aug 15, 2025, 5:35 PM CET
ABIONYX Pharma Revenue
In the year 2024, ABIONYX Pharma had annual revenue of 4.55M EUR, down -1.92%. ABIONYX Pharma had revenue of 2.21M in the half year ending December 31, 2024, a decrease of -15.83%.
Revenue
4.55M
Revenue Growth
-1.92%
P/S Ratio
13.78
Revenue / Employee
89.24K
Employees
51
Market Cap
62.70M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |